Search Results
Sep 02, 2026, 07:00 ET Jianpu Technology Inc. Reports First Half Year 2026 Unaudited Financial Results
36,079Digital intelligence as a service [b]
More news about: Jianpu Technology Inc.
Sep 02, 2026, 06:59 ET Pilot-Operated Gas Regulators Market worth $0.52 billion by 2031 | MarketsandMarkets™
alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.Today,
More news about: MarketsandMarkets
Sep 02, 2026, 06:46 ET Tradr Filed for Long and Short Anthropic ETFs: ANTT & ANTZ
more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively
More news about: Tradr ETFs
Sep 02, 2026, 06:33 ET CSTS Enterprises創下世界盃銷售新高後宣布晉升周艷玲為區域總經理再拓發展新里程
年FIFA世界盃大中華區官方款待項目的表現尤為突出，取得了重大成功，為CSTS的持續擴展提供了堅實的支持。在加入 CSTS 前，周女士在旅遊及款待行業擁有豐富經驗，擅長供應鏈管理及分銷合作夥伴關係。她的領導經驗涵蓋拓展國際供應商網絡、優化渠道表現，推動澳洲及紐西蘭市場發展、以及在上市酒店集團─格林酒店集團（GreenTree Hospitality Group）任職期間專職中國 B2B 分銷及渠道整合等工作，成功擴大亞太區市場版圖。CSTS Enterprises共同創辦人兼首席產品官王文賓表示：「周艷玲女士是一位具遠見的領導者，能將產品創新、策略夥伴關係及市場需求緊密連結，從而為企業創造無可比擬的價值。隨著周女士出任更重要的崗位，我們期待在她的帶領下實現更多新的里程碑。」CSTS
More news about: CSTS Enterprises
Sep 02, 2026, 06:30 ET YSS Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against York Space Systems Inc.
or otherwise acquired York Space Systems Inc. (NYSE: YSS) (a) in connection with the Company's January 2026 initial public offering ("IPO"), and/or (b) securities between January 29, 2026 and May 11, 2026, inclusive (the "Class Period"). York operates as a space and defense provider that primarily sells
More news about: Robbins LLP
Sep 02, 2026, 06:30 ET Hyperscale Data Has Ceased Bitcoin Mining Operations in Michigan as It Fulfills the Requirements of the AI Data Center Master Services Agreement Expected to be Worth Approximately $1.2 Billion
as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the "ACG Shares"). The Company reminds its stockholders that only those holders of the Series F Preferred Stock
More news about: Hyperscale Data Inc.
Sep 02, 2026, 06:10 ET Acer Launches New Aspire Devices for Creators, Gamers, and Families
Series 3The 27-inch Aspire S 27 (S27B-WCLLP) and 23.8-inch Aspire S 24 (S24B-WCLLP) all-in-one desktops are refreshed from the previous generation. Now powered by up to an Intel Core 7 processor 350, they deliver
More news about: Acer
Sep 02, 2026, 06:00 ET NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
anti-Nogo-A biologics for diseases of the central nervous system, today announced the successful completion of a CHF 24 million (USD 30 million) Series B financing round. The round was led by Neurimmune and Pureos, with participation from existing and new investors. The equity financing is complemented
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury
anti-Nogo-A biologics for diseases of the central nervous system, today announced the successful completion of a CHF 24 million (USD 30 million) Series B financing round. The round was led by Neurimmune and Pureos, with participation from existing and new investors. The equity financing is complemented
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET NovaGo Therapeutics schließt Serie-B-Finanzierungsrunde in Höhe von 30 Millionen US-Dollar ab, um die Proof-of-Concept-Studie bei akuter Rückenmarksverletzung voranzutreiben
klinischen Stadium, das Anti-Nogo-A-Biologika für Erkrankungen des Zentralnervensystems entwickelt, gab heute den erfolgreichen Abschluss einer Serie-B-Finanzierungsrunde in Höhe von 24 Millionen CHF (30 Millionen US-Dollar) bekannt. Die Runde wurde von Neurimmune und Pureos angeführt, unter Beteiligung
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET NovaGo Therapeutics clôture un tour de financement de série B de 30 millions de dollars américains pour faire avancer son étude de validation de principe sur les lésions médullaires aiguës
biologiques anti-Nogo-A destinés au traitement des maladies du système nerveux central, a annoncé aujourd'hui avoir mené à bien un tour de financement de série B d'un montant de 24 millions de francs suisses (30 millions de dollars américains). Le tour de table a été mené par Neurimmune et Pureos, avec la participation
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET Acer Unveils Its First FHD 1000 Hz Gaming Monitor - Predator XB253Q U1
Colors1.07 BBits
More news about: Acer
Sep 02, 2026, 06:00 ET NovaGo Therapeutics、急性脊髄損傷における概念実証試験の推進に向け、3,000万米ドルのシリーズB資金調達を完了
View original content to download multimedia:https://www.prnewswire.com/jp/news-releases/novago-therapeutics3-000b-302867175.htmlSOURCE NovaGo Therapeutics
More news about: NovaGo Therapeutics
Sep 02, 2026, 06:00 ET NovaGo Therapeutics cierra una ronda de financiación para un estudio en lesiones agudas de la médula espinal
-NovaGo Therapeutics cierra una ronda de financiación Serie B de 30 millones de dólares para impulsar un estudio de prueba de concepto en lesiones agudas de la médula espinalLa ronda fue liderada por Neurimmune y Pureos, con la participación de inversores
More news about: NovaGo Therapeutics
Sep 02, 2026, 05:57 ET Manipal Hospital Sarjapur Road Encourages People to Opt for Early Screening to Protect Liver Health
bigger concern lies with chronic Hepatitis B and C, which can progress silently from persistent inflammation to fibrosis, cirrhosis, and hepatocellular carcinoma if left undiagnosed. Dr. Syed Ahmed, Consultant – Gastroenterology, noted, "Chronic hepatitis B and C often show no symptoms until liver
More news about: Manipal Hospitals
Sep 02, 2026, 05:55 ET Acer Introduces Veriton RI110 AI Mini Workstation for Powering Hybrid Agentic AI Workloads
Editor's SummaryPowered by an Intel Core Ultra X7 processor 358H and Intel Arc B390 graphics, the new Acer Veriton RI110 delivers high-performance, local AI computing for design, inference, and content creation, with support for AI models of up to 120 billion parameters.The
More news about: Acer
Sep 02, 2026, 05:35 ET Acer Unveils New Vero 16 Laptop - Designed Around Repairability, AI-powered Performance, and a Commitment to Reducing Environmental Impact
Graphics Intel Arc B390Intel Graphics
More news about: Acer
Sep 02, 2026, 05:30 ET Acer Expands Gaming Handheld Portfolio with Predator Atlas 7
Intel Arc B390 graphicsIntel Arc B370 graphics
More news about: Acer
Sep 02, 2026, 05:20 ET 미국 정부 및 노스아메리칸 블루 에너지 파트너스(NABEP), 베네수엘라 석유 부문 개발을 위한 역사적 합의 체결
multimedia:https://www.prnewswire.com/kr/news-releases/uBBF8uAD6Du002DuC815uBD80u002DuBC0Fu002DuB178uC2A4uC544uBA54uB9ACuCE78u002DuBE14uB8E8u002DuC5D0uB108uC9C0u002DuD30CuD2B8uB108uC2A4u0028u006E-302867560.htmlSOURCE
More news about: North American Blue Energy Partners (NABEP)
Sep 02, 2026, 05:18 ET 세미콘 타이완: 작센, 글로벌 반도체 산업을 위한 유럽 최고의 중심지로 자리매김
multimedia:https://www.prnewswire.com/kr/news-releases/uC138uBBF8uCF58u002DuD0C0uC774uC644u003Au002DuC791uC13Cu002Cu002DuAE00uB85CuBC8Cu002DuBC18uB3C4uCCB4u002DuC0B0uC5C5uC744u002DuC704uD55Cu002D-302867556.htmlSOURCE
More news about: Saxony Trade & Invest Corp.
Sep 02, 2026, 05:00 ET Yatsen Announces Second Quarter 2026 Financial Results
Class A ordinary shares, 960,852,606 Class B ordinary shares and 3,039,147,394 shares each of such classes to be designated as of December 31, 2025 and June 30, 2026; 2,096,600,883 Class A shares and 600,572,880 Class B ordinary shares issued as of December 31,2025
More news about: Yatsen Holding Limited
Sep 02, 2026, 04:02 ET Simcere Zaiming schließt exklusive Lizenzvereinbarung mit Roche über die weltweite Entwicklung von SIM0660
beiden B-Zell-Antigene CD79a und CD19 abzielen, um eine starke T-Zell-vermittelte Zytotoxizität zu induzieren und gleichzeitig die Zytokinfreisetzung zu begrenzen. Mit seinem potenziell erstklassigen Dual-Targeting-Ansatz gegen CD79a und CD19 ist SIM0660 darauf ausgelegt, ein breites Spektrum an B-Zell-vermittelten
More news about: Simcere
Sep 02, 2026, 04:00 ET Simcere Zaiming sluit exclusieve licentieovereenkomst met Roche voor wereldwijde ontwikkeling van SIM0660
om een brede dekking te bieden voor B-celgemedieerde ziekten en kan een gedifferentieerde therapeutische benadering bieden voor patiënten die eerder met CD20- of CD19-gerichte therapieën zijn behandeld. Daarnaast heeft SIM0660 ook therapeutisch potentieel voor door B-cellen gemedieerde auto-immuunziekten,
More news about: Simcere
Sep 02, 2026, 04:00 ET CIGRE 2026: Building power grids for a new age of electrification
public authorities must create stable frameworks that enable investment while ensuring affordability and public acceptance."No plan B, no planet B," said Konstantin O. Papailiou, President of CIGRE, calling for collective action to build the power systems of the future. No electrification
More news about: CIGRE
Sep 02, 2026, 04:00 ET CIGRE 2026 : construire les réseaux électriques pour une nouvelle ère de l'électrification
favorisant l'investissement tout en garantissant l'accessibilité financière et l'acceptabilité des projets.« Pas de plan B, pas de planète B », a déclaré Konstantin O. Papailiou, président du CIGRE, appelant à une mobilisation collective pour construire les systèmes électriques du
More news about: CIGRE